Evidence map›Paper›PMID 40574747›Full record

ArticleJournal of magnetism and magnetic materials2025

Characterization and Evaluation of Commercial Tracers for X-Space Magnetic Particle Imaging.

Eric Daniel Imhoff, Andrii Melnyk, Carlos M Rinaldi-Ramos

Abstract read
In one paragraph

Article in Journal of magnetism and magnetic materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Flame-Made Doped Iron Oxide Nanoparticles as Tracers for Magnetic Particle Imaging.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eric Daniel ImhoffDepartment of Chemical Engineering, University of Florida, Gainesville, FL 32611, USA.
Andrii MelnykJ. Crayton Pruitt Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, USA.
Carlos M Rinaldi-RamosDepartment of Chemical Engineering, University of Florida, Gainesville, FL 32611, USA.

Funding

NIH Administrative Supplement to Promote Diversity in Health Related ResearchR01EB031224 · NIBIB · UNIVERSITY OF FLORIDA · PI RINALDI-RAMOS, CARLOS M · 2022 to 2025
$2.4M
NIBIB NIH HHS R01 EB031224
6 · The paper itself

Abstract

Commercial magnetic particle imaging (MPI) tracers are utilized for many applications including as reference materials for comparing tracer performance, but comparative measurements of many tracers on a single imaging platform are uncommon. This study uses relaxometry and 2D imaging in a pre-clinical MOMENTUM scanner to characterize and evaluate the performance of six common commercial tracers for MPI: Synomag-D Plain, Synomag-D NH2, Synomag-D PEG, Perimag, Vivotrax, and Vivotrax Plus. Repeated measurements of samples showed considerable variability while inter-sample differences were generally negligible. Sensitivity between the two modes is strongly correlated while resolution of the two modes was only moderately correlated. Further, relaxometric measurements tend to predict better resolution than is achieved in 2D imaging. All evaluated tracers have resolutions within 1 mm of each other on the MOMENTUM imager. These results illustrate that relaxometer measurements can be used to broadly predict MPI performance but do not accurately recreate the physical processes or differences in hardware and software of MPI. This study provides MPI measurements of tracers that may be useful to researchers while highlighting the challenges of making comparisons between tracers due to variation within samples and across different measurement techniques and instruments.

Indexed as

magnetic nanoparticlesmagnetic particle imagingPerimagSynomagVivotrax

Identifiers

PMID40574747
PMCPMC12201972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.